The story of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in income, its patent expiration created a deluge of generic competition , significantly impacting its market share . While some pharmaceutical companies may attempt to capitalize on male sexual dysfun